Skip to main content

Clearside Biomedical, Inc - Phase I/II Clinical Study

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Feb 12, 2013
Award amount: 
$250,000
Organization name: 
Clearside Biomedical, Inc
Principal Investigator: 
Deignan, Charles A.
Grant program category: 
Business Financing
Grant program name: 
Strategic Growth Loan
Region: 
Research Triangle

Clearside Biomedical is a start-up ophthalmic company developing and eventually commercializing targeted therapeutics for the treatment of sight threatening diseases using a proprietary microneedle technology. The company was awarded a Strategic Growth Loan to partially fund the first clinical study for the company's first product. The study will be managed by North Carolina based employees and vendors from NC will be utilized in conducting the study."

Fiscal year: 
2013